Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1B Study of KCC Peptide Application in the Colon

NCT02156557 is registered in ClinicalTrials.gov with Danielle Kim Turgeon as lead sponsor.

NCT NCT02156557
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02156557 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1B Study of KCC Peptide Application in the Colon
Lead sponsor
Danielle Kim Turgeon
Phase
Phase 1
Overall status
Completed
Start date
June 30, 2014
Completion date
August 31, 2016
Enrollment
45 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colon polyps, colorectal cancer, inflammatory bowel disease (ibd)